ResMed said net revenue for the three months ended September 30, 2024 rose to $1,224.5 million from $1,102.3 million a year earlier, an increase of $122.2 million, or 11%. On a constant currency basis, the increase was 11%.

10-QQuarterly reportFiled Oct 25, 2024Period of report Sep 30, 2024Summary published (UTC) Oct 24, 2026

Key points

AI summary

ResMed said net revenue for the three months ended September 30, 2024 rose to $1,224.5 million from $1,102.3 million a year earlier, an increase of $122.2 million, or 11%. On a constant currency basis, the increase was 11%.
The company said gross profit for the quarter rose 20% to $717.2 million, and gross margin was 58.6%, compared with 54.4% a year earlier. It cited manufacturing efficiencies, component cost improvements, higher average selling prices and lower amortization of acquired intangibles as factors.
The company said net income for the quarter was $311.4 million, compared with $219.4 million a year earlier, an increase of 42%. It said diluted earnings per share were $2.11, compared with $1.49 a year earlier.
The company said cash provided by operating activities for the quarter was $325.5 million. It repurchased shares for $50.0 million and paid cash dividends of $0.53 per share, or $77.9 million in total. Cash and cash equivalents as of September 30, 2024 were $426.4 million.

Key figures

Quarter ended September 30, 2024

Revenue: $1.2B
Operating income: $387M
Net income: $311M
EPS: $2.11
Gross profit: $717M
Operating cash flow: $326M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Quarterly Net Revenue Reached $1,224.5 million

ResMed said net revenue for the three months ended September 30, 2024 rose to $1,224.5 million from $1,102.3 million a year earlier, an increase of $122.2 million, or 11%. On a constant currency basis, the increase was 11%.

Source · Based on the MD&A text of the filing

Gross margin 58.6%

The company said gross profit for the quarter rose 20% to $717.2 million, and gross margin was 58.6%, compared with 54.4% a year earlier. It cited manufacturing efficiencies, component cost improvements, higher average selling prices and lower amortization of acquired intangibles as factors.

Source · Based on the MD&A text of the filing

Net income $311.4 million, diluted EPS $2.11

The company said net income for the quarter was $311.4 million, compared with $219.4 million a year earlier, an increase of 42%. It said diluted earnings per share were $2.11, compared with $1.49 a year earlier.

Source · Based on the MD&A text of the filing

Operating cash flow and share buybacks and dividends

The company said cash provided by operating activities for the quarter was $325.5 million. It repurchased shares for $50.0 million and paid cash dividends of $0.53 per share, or $77.9 million in total. Cash and cash equivalents as of September 30, 2024 were $426.4 million.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.